Renaissance Technologies’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-89,683
| Closed | -$1.94M | – | 4546 |
|
|
2022
Q4 | $1.94M | Sell |
89,683
-50,000
| -36% | -$1.06M | ﹤0.01% | 2090 |
|
|
2022
Q3 | $2.7M | Buy |
139,683
+120,183
| +616% | +$2.49M | ﹤0.01% | 1832 |
|
|
2022
Q2 | $387K | Buy |
19,500
+9,900
| +103% | +$261K | ﹤0.01% | 3309 |
|
|
2022
Q1 | $286K | Buy |
+9,600
| New | +$281K | ﹤0.01% | 3492 |
|
|
2019
Q3 | – | Sell |
-10,248
| Closed | -$330K | – | 3807 |
|
|
2019
Q2 | $330K | Sell |
10,248
-14,200
| -58% | -$475K | ﹤0.01% | 3143 |
|
|
2019
Q1 | $787K | Sell |
24,448
-13,284
| -35% | -$358K | ﹤0.01% | 2772 |
|
|
2018
Q4 | $926K | Sell |
37,732
-4,400
| -10% | -$116K | ﹤0.01% | 2612 |
|
|
2018
Q3 | $1.39M | Sell |
42,132
-65,234
| -61% | -$2.13M | ﹤0.01% | 2465 |
|
|
2018
Q2 | $3.81M | Buy |
107,366
+14,934
| +16% | +$484K | ﹤0.01% | 1948 |
|
|
2018
Q1 | $3.01M | Sell |
92,432
-28,300
| -23% | -$953K | ﹤0.01% | 2103 |
|
|
2017
Q4 | $3.09M | Sell |
120,732
-14,800
| -11% | -$375K | ﹤0.01% | 2097 |
|
|
2017
Q3 | $2.84M | Sell |
135,532
-9,900
| -7% | -$236K | ﹤0.01% | 2107 |
|
|
2017
Q2 | $3M | Sell |
145,432
-4,200
| -3% | -$86.2K | ﹤0.01% | 2033 |
|
|
2017
Q1 | $3.59M | Buy |
149,632
+794
| +0.5% | +$17.3K | 0.01% | 1904 |
|
|
2016
Q4 | $2.64M | Buy |
148,838
+17,338
| +13% | +$360K | ﹤0.01% | 2076 |
|
|
2016
Q3 | $1.7M | Buy |
131,500
+12,518
| +11% | +$148K | ﹤0.01% | 2288 |
|
|
2016
Q2 | $1.11M | Buy |
118,982
+5,812
| +5% | +$64.1K | ﹤0.01% | 2486 |
|
|
2016
Q1 | $1.12M | Buy |
113,170
+15,020
| +15% | +$134K | ﹤0.01% | 2536 |
|
|
2015
Q4 | $1.01M | Buy |
98,150
+79,077
| +415% | +$818K | ﹤0.01% | 2457 |
|
|
2015
Q3 | $252K | Sell |
19,073
-1,190
| -6% | -$30K | ﹤0.01% | 2841 |
|
|
2015
Q2 | $626K | Buy |
20,263
+4,034
| +25% | +$136K | ﹤0.01% | 2652 |
|
|
2015
Q1 | $579K | Buy |
16,229
+10,204
| +169% | +$430K | ﹤0.01% | 2542 |
|
|
2014
Q4 | $240K | Buy |
6,025
+3,915
| +186% | +$172K | ﹤0.01% | 2642 |
|
|
2014
Q3 | $106K | Sell |
2,110
-5,412
| -72% | -$311K | ﹤0.01% | 2652 |
|
|
2014
Q2 | $487K | Buy |
7,522
+1,359
| +22% | +$94.5K | ﹤0.01% | 2335 |
|
|
2014
Q1 | $505K | Buy |
6,163
+1,313
| +27% | +$119K | ﹤0.01% | 2355 |
|
|
2013
Q4 | $332K | Buy |
+4,850
| New | +$355K | ﹤0.01% | 2483 |
|
|
2013
Q3 | – | Sell |
-1,306
| Closed | -$164K | – | 2987 |
|
|
2013
Q2 | $164K | Buy |
+1,306
| New | +$136K | ﹤0.01% | 2553 |
|
Other funds holding ALBO
Renaissance Technologies's ALBO Position: Q1 2023 in Review
Renaissance Technologies sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 89,683 shares — an estimated $1.94M sold.
Renaissance Technologies first reported a position in ALBO in Q2 2013 and held it in 28 quarters. The position peaked at $3.81M in Q2 2018. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Renaissance Technologies reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Renaissance Technologies sold 89,683 Albireo Pharma Inc shares in Q1 2023, an estimated $1.94M.
- Renaissance Technologies first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 28 quarters.
- Renaissance Technologies's Albireo Pharma Inc position peaked at $3.81M in Q2 2018.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.